Authoritative information and practical advice from the nation's cancer experts about AIDS-related lymphoma and primary CNS lymphoma includes official medical data on signs, symptoms, treatment options, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment ofAIDS-related lymphoma and primary CNS lymphoma.AIDS-related lymphoma is a disease in which malignant (cancer) cells form in the lymph system of patients who have acquired immunodeficiency syndrome (AIDS). AIDS is caused by the human immunodeficiency virus (HIV), which attacks and weakens the body's immune system. The immune system is then unable to fight infection and diseases that invade the body. People with HIV disease have an increased risk of developing infections, lymphoma, and other types of cancer. A person with HIV disease who develops certain types of infections or cancer is then diagnosed with AIDS. Sometimes, people are diagnosed with AIDS and AIDS-related lymphoma at the same time. Lymphomas are cancers that affect the white blood cells of the lymph system, part of the body's immune system.Lymphocytes (carried in the lymph) travel in and out of the central nervous system (CNS). It is thought that some of these lymphocytes become malignant and cause lymphoma to form in the CNS. Primary CNS lymphoma can start in the brain, spinal cord, or meninges (the layers that form the outer covering of the brain). Because the eye is so close to the brain, primary CNS lymphoma can also start in the eye (called ocular lymphoma). Primary CNS lymphoma may occur in patients who have acquired immunodeficiency syndrome (AIDS) or other disorders of the immune system or who have had a kidney transplant.Comprehensive data on clinical trials related to these cancers is included - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:Levels of Evidence for Cancer Treatment StudiesGlossary of Clinical Trial TermsClinical Trials Background Information and In-Depth ProgramClinical Trials at NIHHow To Find A Cancer Treatment Trial: A Ten-Step GuideTaking Part in Cancer Treatment Research StudiesAccess to Investigational DrugsClinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical CenterTaking Time: Support for People with CancerFacing Forward - Life After Cancer TreatmentChemotherapy and YouThis is a privately authored news service and educational publication of Progressive Management. For over a quarter of a century, our news, educational, technical, scientific, and medical publications have made unique and valuable references...